Webinar

October 15, 2026 |  4pm CET I 10am ET  

Introducing Advyser BloodSuite - RHD: Smarter analysis for Devyser RHD 

Non-invasive fetal RHD screening supports targeted anti-D prophylaxis, helping avoid unnecessary treatment while identifying pregnancies where anti-D prophylaxis may be indicated. In this webinar, we will briefly introduce the role of RHD screening with Devyser RHD, our real-time PCR assay, followed by a practical demonstration of Advyser BloodSuite – RHD, the software that supports analysis and interpretation of Devyser RHD results.

In this webinar, we will explore:

• Understand the Rh blood group system, its clinical significance in pregnancy, and how fetal RHD screening supports targeted anti-D prophylaxis as per with the current recommendations
• Get an overview of Devyser RHD and its real-time PCR workflow
• Get a demo of Advyser BloodSuite -RHD and learn how it supports data analysis of results from Devyser RHD
  
  Feel free to submit your questions in advance if you want them addressed during the webinar by replying to this email. 
  
  Can’t attend live?
  Everyone who registers will receive access to the on-demand recording after the webinar.